Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127903821 | 12790382 | 1 | I | 201606 | 20120724 | 20160928 | 20160928 | PER | US-ASTRAZENECA-2012SE52070 | ASTRAZENECA | 463.00 | MON | F | Y | 137.80000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127903821 | 12790382 | 1 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
127903821 | 12790382 | 2 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | N | U | 21366 | TABLET | ||||||||
127903821 | 12790382 | 3 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0 | .5 | MG | Q6H | ||||||||
127903821 | 12790382 | 4 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 0 | 5 | MG | /hr | ||||||||
127903821 | 12790382 | 5 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
127903821 | 12790382 | 6 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
127903821 | 12790382 | 7 | C | SUMATRIPTAN SUCCINATE. | SUMATRIPTAN SUCCINATE | 1 | 50.0MG UNKNOWN | 0 | 50 | MG | |||||||||
127903821 | 12790382 | 8 | C | VITAMIN-B12-FOLIC ACID | 2 | 500-400 MCG | 0 | ||||||||||||
127903821 | 12790382 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | 1000 | MG | QD | |||||||||
127903821 | 12790382 | 10 | C | CETRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
127903821 | 12790382 | 11 | C | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | 1 | 0 | ||||||||||||
127903821 | 12790382 | 12 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 500 | MG | BID | |||||||||
127903821 | 12790382 | 13 | C | VYTORIN | EZETIMIBESIMVASTATIN | 1 | 10-40 MG DAILY | 0 | |||||||||||
127903821 | 12790382 | 14 | C | RANITIDINE HCL | RANITIDINE HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | TABLET | BID | |||||||
127903821 | 12790382 | 15 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | 50-325-40 MG, AS NEEDED | 0 | CAPSULE | ||||||||||
127903821 | 12790382 | 16 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 5-500 MG | 0 | |||||||||||
127903821 | 12790382 | 17 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0 | .9 | MG | TABLET | QD | |||||||
127903821 | 12790382 | 18 | C | PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
127903821 | 12790382 | 19 | C | REXULTI | BREXPIPRAZOLE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
127903821 | 12790382 | 20 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
127903821 | 12790382 | 21 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 50MCG/ 2 SPRAYS EACH NOSTRIL | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127903821 | 12790382 | 2 | Hyperlipidaemia |
127903821 | 12790382 | 17 | Hormone replacement therapy |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127903821 | 12790382 | Drug hypersensitivity | |
127903821 | 12790382 | Eye pain | |
127903821 | 12790382 | Facial pain | |
127903821 | 12790382 | Headache | |
127903821 | 12790382 | Myalgia | |
127903821 | 12790382 | Nasal congestion | |
127903821 | 12790382 | Rhinalgia | |
127903821 | 12790382 | Sinus operation | |
127903821 | 12790382 | Sinusitis | |
127903821 | 12790382 | Teething | |
127903821 | 12790382 | Throat irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |